Details for Patent: 11,771,701
✉ Email this page to a colleague
Which drugs does patent 11,771,701 protect, and when does it expire?
Patent 11,771,701 protects JYLAMVO and is included in one NDA.
This patent has twenty-three patent family members in eighteen countries.
Drugs Protected by US Patent 11,771,701
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WITH AN ORAL SOLUTION OF METHOTREXATE | ⤷ Subscribe | |||
Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF ADULTS WITH MYCOSIS FUNGOIDES WITH AN ORAL SOLUTION OF METHOTREXATE | ⤷ Subscribe | |||
Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMAS WITH AN ORAL SOLUTION OF METHOTREXATE | ⤷ Subscribe | |||
Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF ADULTS WITH RHEUMATOID ARTHRITIS WITH AN ORAL SOLUTION OF METHOTREXATE | ⤷ Subscribe | |||
Shorla | JYLAMVO | methotrexate | SOLUTION;ORAL | 212479-001 | Nov 29, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF ADULTS WITH SEVERE PSORIASIS WITH AN ORAL SOLUTION OF METHOTREXATE | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,771,701
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015340373 | ⤷ Subscribe | |||
Canada | 3002493 | ⤷ Subscribe | |||
China | 107106485 | ⤷ Subscribe | |||
China | 116747190 | ⤷ Subscribe | |||
Cyprus | 1125033 | ⤷ Subscribe | |||
Denmark | 3212237 | ⤷ Subscribe | |||
European Patent Office | 3212237 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |